Actively Recruiting
Unconscious Reduction of Fear Through Decoded Neuro-Reinforcement
Led by University of California, Los Angeles · Updated on 2025-10-02
60
Participants Needed
1
Research Sites
107 weeks
Total Duration
On this page
Sponsors
U
University of California, Los Angeles
Lead Sponsor
N
National Institute of Mental Health (NIMH)
Collaborating Sponsor
AI-Summary
What this Trial Is About
This application investigates the efficacy of a novel method of neuro-reinforcement based on decoded fMRI activity to reduce fear responses in individuals with phobias (e.g., spiders, snakes). This method works unconsciously in the brain, without the need for participants to endure repeated conscious exposures to their feared stimuli. Fear-related disorders such as specific phobia, post-traumatic stress disorder (PTSD), and other anxiety disorders present a major challenge, as effective treatment options usually involve repeated exposures to feared stimuli, leading to high levels of distress, fear, and panic that can motivate premature treatment termination. Consequently, there is an unmet need for treatment that minimizes subjective discomfort and attrition in order to maximize efficacy. Recent developments in computational neuroimaging have enabled a method that can deliver unconscious exposure to feared stimuli, resulting in effective fear reduction while bypassing a primary cause of treatment attrition. Because this treatment method happens unconsciously in the brain, changes in behavior outcomes are potentially more likely to generalize to different contexts, thereby overcoming a limitation of traditional treatments.
CONDITIONS
Official Title
Unconscious Reduction of Fear Through Decoded Neuro-Reinforcement
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Individual has normal or corrected to normal vision
- Individual has normal or corrected to normal hearing
- Individual is competent to understand informed consent
- Individual must meet DSM-5 diagnostic criteria for specific animal phobias
You will not qualify if you...
- Individual is unable to fill in consent form correctly
- Individual is unable to respond adequately to screening questions
- Individual is unable to maintain focus or sit during assessment
- History of neurological disease, stroke, brain injury, schizophrenia, seizures, or other psychological disorders
- Presence of vision problems such as cataracts, amblyopia, or glaucoma
- Diagnosis of Obsessive Compulsive Disorder, Substance Use Disorder, Bipolar Disorder, Psychosis, or unstable serious medical conditions
- Elevated score on the PHQ-9 depression questionnaire
- More than one specific phobia object
- Can touch the phobic object during pre-treatment test without significant distress
- Currently prescribed psychotropic medication
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
University of California, Los Angeles
Los Angeles, California, United States, 90095
Actively Recruiting
Research Team
G
Gabriel J Fiol, B.A.
CONTACT
K
Kainoa R MacDonald, B.A.
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
TRIPLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
3
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here